neoviibiotech.com
#48,839,807
Global Rankeez rank
Better than 51.4% of the 100,511,422 domains we track
Best rank recorded
#48,839,807
2026-11
Worst rank recorded
#48,852,772
2026-07
Tracked since
2026-07
4 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how neoviibiotech.com scores in each:
| Source | Rank |
|---|---|
| CommonCrawl (hyperlink graph) | #85,335,709 |
See how these sources are combined and cross-validated →
Ranking history
neoviibiotech.com's rank across 4 monthly snapshots. ▲ improved by 12,965 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #48,852,772 |
| 2026-08 | #48,845,454 |
| 2026-10 | #48,841,598 |
| 2026-11 | #48,839,807 |
JSON API
{
"neoviibiotech.com": 48839807,
"history": {
"2026-07": 48852772,
"2026-08": 48845454,
"2026-10": 48841598,
"2026-11": 48839807
}
}
GET https://rankeez.com/api/neoviibiotech.com.json · see API docs →
More about neoviibiotech.com
neoviibiotech.com — page content & similar sites →
Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in over 50 countries world
neoviibiotech.com — full site profile →
WHOIS, tech stack and extended traffic history for neoviibiotech.com.